These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6675892)

  • 1. The Coronary Drug Project. Role and methods of the Drug Procurement and Distribution Center.
    Brennan EC
    Control Clin Trials; 1983 Dec; 4(4):409-17. PubMed ID: 6675892
    [No Abstract]   [Full Text] [Related]  

  • 2. The Coronary Drug Project. Role and methods of the ECG Reading Center.
    Prineas RJ; Blackburn H
    Control Clin Trials; 1983 Dec; 4(4):389-407. PubMed ID: 6675891
    [No Abstract]   [Full Text] [Related]  

  • 3. The Coronary Drug Project. Role and methods of the Coordinating Center.
    Meinert CL; Heinz EC; Forman SA
    Control Clin Trials; 1983 Dec; 4(4):355-75. PubMed ID: 6675890
    [No Abstract]   [Full Text] [Related]  

  • 4. The Coronary Drug Project. External quality control programs.
    Canner PL; Krol WF; Forman SA
    Control Clin Trials; 1983 Dec; 4(4):441-66. PubMed ID: 6675895
    [No Abstract]   [Full Text] [Related]  

  • 5. The Coronary Drug Project. Role and methods of the clinical centers.
    Berge KG; Laubach CA; Hutchinson RG
    Control Clin Trials; 1983 Dec; 4(4):419-27. PubMed ID: 6675893
    [No Abstract]   [Full Text] [Related]  

  • 6. The Coronary Drug Project. Organizational structure of the study.
    Canner PL; Stamler J
    Control Clin Trials; 1983 Dec; 4(4):333-43. PubMed ID: 6675888
    [No Abstract]   [Full Text] [Related]  

  • 7. The Coronary Drug Project. Experimental design features.
    Canner PL; Klimt CR
    Control Clin Trials; 1983 Dec; 4(4):313-32. PubMed ID: 6675887
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution and funding of the Coronary Drug Project.
    Zukel WJ
    Control Clin Trials; 1983 Dec; 4(4):281-312. PubMed ID: 6675886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in smaller plants].
    Baeschlin K
    Pharm Acta Helv; 1973; 48(6):358-70. PubMed ID: 4729557
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in large plants].
    Hinsen W
    Pharm Acta Helv; 1973; 48(6):322-38. PubMed ID: 4729555
    [No Abstract]   [Full Text] [Related]  

  • 11. The federal pharmacy: a half-century of permanence.
    Griffin RJ
    Am Pharm; 1979 May; 19(5):14-5. PubMed ID: 382815
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infusion center of the Gera District].
    Wilhelm A
    Pharm Prax; 1970; 3():52-3. PubMed ID: 5430536
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug standards in military procurement.
    Feinberg M
    J Am Pharm Assoc; 1969 Mar; 9(3):113-6 passim. PubMed ID: 5781991
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the Coronary Drug Project findings on clinical practice.
    Friedman L; Wenger NK; Knatterud GL
    Control Clin Trials; 1983 Dec; 4(4):513-22. PubMed ID: 6675899
    [No Abstract]   [Full Text] [Related]  

  • 16. Integration of formulary systems with centralized pharmaceutical procurement.
    Smith EB; Hope SM; Halstead SK; Ford WM
    Hosp Formul; 1990 Feb; 25(2):193-6, 198. PubMed ID: 10170504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Coronary Drug Project. Role of the National Institutes of Health.
    Zukel WJ; Halperin M; Friedman L; Darby EM
    Control Clin Trials; 1983 Dec; 4(4):345-54. PubMed ID: 6675889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief description of the Coronary Drug Project and other studies.
    Canner PL
    Control Clin Trials; 1983 Dec; 4(4):273-80. PubMed ID: 6373137
    [No Abstract]   [Full Text] [Related]  

  • 19. Including management criteria for hazardous drugs in the drug procurement process.
    Guiu Segura JM; Bossacoma Busquets F; Aguilar Barcons I; Gilabert Perramon A
    Res Social Adm Pharm; 2018 Aug; 14(8):795-796. PubMed ID: 29759908
    [No Abstract]   [Full Text] [Related]  

  • 20. Essential medicines in the Third World.
    D'Arcy PF
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):982-4. PubMed ID: 6435751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.